Moreover, mTOR inhibition by administration of rapamycin or overexpression of wild-type p62 could ameliorate this phenotype while expression of the ALS/FTD-associated P392L p62 mutant could not [184]. The gene discussed is SQSTM1; the disease is amyotrophic lateral sclerosis.